These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9408323)

  • 1. Impaired T cell functions preceding lymphoproliferative disorders in mice neonatally tolerized to transplantation antigens.
    Jánossy T; Vizler C; Ocsovszki I; Tibbe GJ; Pipis J; Savelkoul HF; Végh P; Benner R
    Acta Chir Hung; 1997; 36(1-4):150-1. PubMed ID: 9408323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmunity, hyporeactivity to T cell mitogens and lymphoproliferative disorders following neonatal induction of transplantation tolerance in mice.
    Jánossy T; Baranyi L; Knulst AC; Vizler C; Benner R; Kelényi G; Végh P
    Eur J Immunol; 1993 Nov; 23(11):3011-20. PubMed ID: 8223878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-versus-graft disease in mice after the induction of neonatal transplantation tolerance by two different methods.
    Pipis J; Jánossy T; Modok S; Ocsovszki I; Hidvégi Z; Horváth G; Végh P; Benner R
    Acta Chir Hung; 1997; 36(1-4):280-1. PubMed ID: 9408374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive transfer of unresponsiveness to allogeneic skin grafts with hepatic gamma delta + T cells.
    Gorczynski RM
    Immunology; 1994 Jan; 81(1):27-35. PubMed ID: 8132216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of donor chimerism, alloreactive host T cells and memory cell development in thymi from mice resistant to neonatal transplantation tolerance.
    Ruiz P; Nassiri M; Viciana AL; Padmanabhan J; Streilein JW
    J Immunol; 1995 Jan; 154(2):633-43. PubMed ID: 7814872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR; Majewski D; Ozker K; Hanson G
    J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of neonatal transplantation tolerance and lymphoproliferative disorders in mice: the role of F1 donor cells.
    Jánossy T; Baranyi L; Vizler C; Nyirati I; Végh P
    Transplant Proc; 1995 Feb; 27(1):188-90. PubMed ID: 7878968
    [No Abstract]   [Full Text] [Related]  

  • 9. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
    Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA; Flye MW
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation.
    Fehr T; Takeuchi Y; Kurtz J; Wekerle T; Sykes M
    Eur J Immunol; 2005 Sep; 35(9):2679-90. PubMed ID: 16082727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in expression of T-cell activation-related molecules and cytokines during tolerance induction in an allogeneic skin transplantation murine model.
    Lee EN; Kim EY; Lee J; Lee HJ; Lee KW; Joh JW; Lee SK; Lee DS; Lee HH; Kim SJ
    Transplant Proc; 2004 Oct; 36(8):2425-8. PubMed ID: 15561268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells.
    Tang W; Yang Y; Zhang F; Li YC; Zhou R; Wang JX; Zhu YN; Li XY; Yang YF; Zuo JP
    Int Immunopharmacol; 2005 Dec; 5(13-14):1904-13. PubMed ID: 16275625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early loss of precursors of CTL and IL 2-producing cells in the development of neonatal tolerance to alloantigens.
    Carnaud C; Ishizaka ST; Stutman O
    J Immunol; 1984 Jul; 133(1):45-51. PubMed ID: 6233373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
    Jones SC; Friedman TM; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
    Mukherjee S; Ahmed A; Nandi D
    J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell proliferative responses to a mitogen derived from Mycoplasma arthritidis are controlled by the accessory cell.
    Lynch DH; Gurish MF; Cole BC; Daynes RA
    J Immunol; 1983 Oct; 131(4):1702-6. PubMed ID: 6413576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
    J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.